levodopa has been researched along with Pyrexia in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (36.36) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Katsuno, M; Komori, S; Nakamura, T; Suzuki, M; Tsuboi, T | 1 |
| Chansysouphanthong, T; Cui, G; Raza, HK; Xu, C; Zhang, W; Zu, J | 1 |
| Di Vico, IA; Novelli, A; Ramat, S; Sorbi, S; Terenzi, F | 1 |
| Doyu, M; Ibi, T; Niwa, J; Taguchi, S | 1 |
| Ablordeppey, E; Taylor, B; Whitman, CB | 1 |
| Ngamreungphong, S; Nugent, K; Singhatiraj, E | 1 |
| Hanyu, N; Hashimoto, T; Tabata, K; Tokuda, T; Yanagisawa, N | 1 |
| CAHN, J; HELBECQUE, C; HEROLD, M; JUILLARD, AM | 1 |
| Ward, C | 1 |
| Douglas, A; Morris, J | 1 |
| Klusha, VE; Kozlovskaia, MM; Svirskis, ShV; Val'dman, AV | 1 |
| West, AP | 1 |
| Hirai, S; Kondo, T; Mizuno, Y; Mori, H; Suda, K; Tanabe, K; Yokochi, F | 1 |
| Berlot, G; Cociancich, N; Gullo, A; Tomasini, A; Viviani, M | 1 |
| Desiles, M; Puech, AJ; Rips, R | 1 |
| Sicuteri, F | 1 |
| Liebschutz, J; Moskowitz, MA; Munro, HN; Nowak, TS; Rubin, D; Wurtman, RJ | 1 |
| Roszkowski, AP; Schuler, ME | 1 |
| Altus, P; Hencey, MA; Weissman, MS | 1 |
| Cunningham, MA; Darby, DG; Donnan, GA | 1 |
| Ito, H; Kikuchi, H; Noda, S; Yamamoto, A; Yamamoto, H | 1 |
| Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G | 1 |
1 review(s) available for levodopa and Pyrexia
| Article | Year |
|---|---|
Dyskinesia and hyperpyrexia syndrome: A case report and review of the literature.
Topics: Dyskinesias; Fever; Humans; Levodopa | 2021 |
21 other study(ies) available for levodopa and Pyrexia
| Article | Year |
|---|---|
[Dyskinesia-hyperpyrexia syndrome triggered by overdose of istradefylline: a case report].
Topics: Aged; Antiparkinson Agents; Drug Overdose; Dyskinesias; Female; Fever; Humans; Levodopa; Parkinson Disease; Purines | 2022 |
Dyskinesia-Hyperpyrexia Syndrome in Parkinson's disease with Deep Brain Stimulation and high-dose levodopa/carbidopa and entacapone.
Topics: Antiparkinson Agents; Carbidopa; Catechols; Combined Modality Therapy; Deep Brain Stimulation; Drug Combinations; Drug Therapy, Combination; Fever; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease | 2019 |
[Dyskinesia-hyperpyrexia syndrome in a patient with Parkinson's disease: a case report].
Topics: Aged; Benzothiazoles; Delayed-Action Preparations; Drug Substitution; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pramipexole; Selegiline | 2015 |
Levodopa Withdrawal Presenting as Fever in a Critically Ill Patient Receiving Concomitant Enteral Nutrition.
Topics: Aged; Combined Modality Therapy; Enteral Nutrition; Fever; Food-Drug Interactions; Humans; Levodopa; Male; Substance Withdrawal Syndrome | 2016 |
Acute dopamine depletion syndrome.
Topics: Aged; Alzheimer Disease; Confusion; Creatine Kinase; Dopamine; Dopamine Agents; Female; Fever; Humans; Hypothyroidism; Levodopa; Muscle Rigidity; Parkinson Disease | 2010 |
Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dehydration; Female; Fever; Health Status; Humans; Incidence; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Risk Factors; Substance Withdrawal Syndrome | 2003 |
[ACTION OF DIFFERENT INHIBITORS OF L-DOPA-5-HTP DECARBOXYLASE ON AN INDUCED HYPERTHERMIA OF CENTRAL ORIGIN].
Topics: 5-Hydroxytryptophan; Dopa Decarboxylase; Enzyme Inhibitors; Fever; Hyperthermia, Induced; Levodopa; Pharmacology; Rats; Research | 1963 |
Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Topics: Aged; Antiparkinson Agents; Confusion; Dantrolene; Deep Brain Stimulation; Dehydration; Dopamine Agents; Drug Monitoring; Electrolytes; Fever; Humans; Leukocyte Count; Levodopa; Magnetic Resonance Imaging; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Nurse's Role; Nursing Assessment; Parkinson Disease; Physical Examination; Substance Withdrawal Syndrome; Time Factors; Urinalysis | 2005 |
It was not just a heatwave! Neuroleptic malignant-like syndrome in a patient with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Female; Fever; Humans; Levodopa; Parkinson Disease; Substance Withdrawal Syndrome | 2006 |
[Psychopharmacologic spectrum of melanostatin].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Biogenic Amines; Brain Chemistry; Catalepsy; Cats; Depression; Emotions; Fever; Haloperidol; Humans; Levodopa; Motor Activity; MSH Release-Inhibiting Hormone; Reserpine | 1980 |
Treatments for neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Catatonia; Electroconvulsive Therapy; Fever; Humans; Levodopa; Male | 1984 |
[A 75-year-old man with parkinsonism and delirium].
Topics: Aged; Delirium; Fever; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substantia Nigra | 1994 |
Drug-induced hyperthermia in a patient with persistent vegetative state. Case report and review of the literature.
Topics: Adult; Body Temperature; Bromocriptine; Fever; Follow-Up Studies; Humans; Levodopa; Male; Time Factors | 1995 |
Is a dopaminergic system involved in thyrotropin releasing hormone induced hyperthermia and in its potentiation by amphetamine?
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Apomorphine; Chlorpromazine; Dopamine; Dopamine Agents; Female; Fever; Haloperidol; Levodopa; Methyltyrosines; Mice; Neurotransmitter Agents; p-Chloroamphetamine; Pimozide; Thyrotropin-Releasing Hormone | 1979 |
Hypothesis: migraine, a central biochemical dysnociception.
Topics: Adult; Animals; Apomorphine; Circadian Rhythm; Dopamine; Female; Fever; Headache; Humans; Levodopa; Lysergic Acid Diethylamide; Male; Migraine Disorders; Nervous System; Norepinephrine; Pain; Perceptual Disorders; Phenylalanine; Psilocybin; Rats; Reserpine; Serotonin; Sleep; Somatosensory Cortex; Synaptic Transmission | 1976 |
The permissive role of hyperthermia in the disaggregation of brain polysomes by L-dopa or D-amphetamine.
Topics: Animals; Body Temperature; Brain; Dextroamphetamine; Fever; Levodopa; Male; Polyribosomes; Rats; Temperature | 1977 |
Effects of corticoids on experimentally induced depression.
Topics: Adrenal Cortex Hormones; Animals; Antidepressive Agents; Body Temperature; Corticosterone; Fever; Hydrocortisone; Levodopa; Male; Mice; Pargyline; Prednisone; Reserpine; Time Factors | 1975 |
A 73-year-old woman with confusion, rigidity, and fever.
Topics: Aged; Carbidopa; Confusion; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Muscle Rigidity; Neuroleptic Malignant Syndrome; Parkinson Disease | 1991 |
Controlled-release delivery of L-dopa associated with nonfatal hyperthermia, rigidity, and autonomic dysfunction.
Topics: Adult; Autonomic Nervous System Diseases; Benserazide; Delayed-Action Preparations; Drug Combinations; Fever; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease | 1991 |
[Case of malignant syndrome suggesting a central hyperthermic mechanism].
Topics: Antidepressive Agents; Female; Fever; Humans; Hypothalamus; Levodopa; Middle Aged; Morpholines; Neuroleptic Malignant Syndrome | 1991 |
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine | 1985 |